← Open Payments lookup

KARLA JONES-GIPSON: Open Payments

NPI 1245719483 · SHREVEPORT, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,565 in 64 payments from 13 companies in 2025. Trend: 2023 $652 · 2024 $1,384 · 2025 $1,565

Food & beverage: $1,454Education: $111
CompanyPaymentsAmount
E.R. Squibb & Sons, L.L.C.17$474
Neurocrine BioSciences, Inc.17$320
Axsome Therapeutics, Inc.6$249
Teva Pharmaceuticals USA, Inc.2$130
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)6$93
Alkermes, Inc.5$83
Otsuka America Pharmaceutical, Inc.3$70
ABBVIE INC.2$36
Janssen Pharmaceuticals, Inc2$30
Boehringer Ingelheim Pharmaceuticals, Inc.1$27

Products named: COBENFY, INGREZZA, Auvelity, CAPLYTA, ARISTADA, VRAYLAR, INVEGA SUSTENNA, ABILIFY ASIMTUFII.

Industry payments across LA — which companies pay providers there.